Theon Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 8.75 Cr
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 185.80 Cr
- Satisfied Charges ₹ 35.44 Cr
- Revenue Growth -4.94%
- Profit Growth -51.16%
- Ebitda -53.13%
- Net Worth 4.18%
- Total Assets 5.15%
About Theon Pharmaceuticals
Theon Pharmaceuticals Limited (TPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 26 May 2005 and has a history of 19 years and eight months. Its registered office is in Chandigarh, Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.75 Cr.
The company currently has active open charges totaling ₹185.80 Cr. The company has closed loans amounting to ₹35.44 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Theon Pharmaceuticals Limited India is Sharad Saxena as CFO. Parul Arora, Puran Joshi, Vidushi Khattar, and Five other members serve as directors at the Company.
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231CH2005PLC028465
- Company No.
028465
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 May 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Theon Pharmaceuticals Limited offer?
Theon Pharmaceuticals Limited offers a wide range of products and services, including Medical Laboratory Instruments, VTM Kit Raw Materials.
Who are the key members and board of directors at Theon Pharmaceuticals?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sharad Saxena | CFO | 19-Nov-2022 | Current |
Amit Bansal ![]() | Managing Director | 08-Jul-2005 | Current |
Board Members (7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Puneet Bansal ![]() | Whole-Time Director | 10-May-2006 | Current |
Parul Arora ![]() | Director | 15-Dec-2017 | Current |
Puran Joshi ![]() | Whole-Time Director | 30-Sep-2010 | Current |
Vidushi Khattar ![]() | Director | 26-Jun-2017 | Current |
Manish Bansal ![]() | Whole-Time Director | 08-Jul-2005 | Current |
Anshul Bansal ![]() | Whole-Time Director | 27-May-2005 | Current |
Financial Performance of Theon Pharmaceuticals.
Theon Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.94% decrease. The company also saw a substantial fall in profitability, with a 51.16% decrease in profit. The company's net worth moved up by a moderate rise of 4.18%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Theon Pharmaceuticals?
In 2023, Theon Pharmaceuticals had a promoter holding of 63.86% and a public holding of 36.14%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹185.80 Cr
₹35.44 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 73.50 Cr
- Axis Bank Limited : 60.00 Cr
- Others : 52.00 Cr
- Governor Of Himachal Pradesh (Through Gm Industries Centre) : 0.30 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
17 Mar 2023 | Hdfc Bank Limited | ₹28.50 Cr | Open |
23 Mar 2022 | Axis Bank Limited | ₹60.00 Cr | Open |
10 Jun 2021 | Others | ₹7.00 Cr | Open |
27 Jul 2016 | Others | ₹5.00 Cr | Open |
01 Mar 2016 | Others | ₹40.00 Cr | Open |
How Many Employees Work at Theon Pharmaceuticals?
Theon Pharmaceuticals has a workforce of 700 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Theon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theon Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.